Epoprostenol in pregnant patients with secondary pulmonary hypertension: Two case reports and a review of the literature

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Women who present with pulmonary hypertension during gestation have traditionally been persuaded to terminate their pregnancy. Historically, the mortality associated with this group is very high. Certain patients with a secondary cause of pulmonary hypertension are believed to share similar pathophysiology with primary pulmonary hypertension patients. Recently, new treatments have become available that have slowed disease progression. We present the successful treatment of two patients who presented during late gestation with moderate pulmonary hypertension. Both patients were managed with intravenous vasodilators and anticoagulants without complication. Each patient successfully delivered a healthy child via spontaneous vaginal delivery. The review of the historical management of similar patients including new insights into the etiology of pulmonary arterial hypertension is also included. It highlights the complexity involved in managing such patients and the requirement of a multidisiplinary team approach.

Original languageEnglish (US)
Pages (from-to)29-34
Number of pages6
JournalTreatments in Respiratory Medicine
Volume3
Issue number1
DOIs
StatePublished - 2004

Fingerprint

Epoprostenol
Pulmonary Hypertension
Pregnancy
Vasodilator Agents
Anticoagulants
Disease Progression
Mortality
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

@article{f781dec770f54f9d928ed136971bc137,
title = "Epoprostenol in pregnant patients with secondary pulmonary hypertension: Two case reports and a review of the literature",
abstract = "Women who present with pulmonary hypertension during gestation have traditionally been persuaded to terminate their pregnancy. Historically, the mortality associated with this group is very high. Certain patients with a secondary cause of pulmonary hypertension are believed to share similar pathophysiology with primary pulmonary hypertension patients. Recently, new treatments have become available that have slowed disease progression. We present the successful treatment of two patients who presented during late gestation with moderate pulmonary hypertension. Both patients were managed with intravenous vasodilators and anticoagulants without complication. Each patient successfully delivered a healthy child via spontaneous vaginal delivery. The review of the historical management of similar patients including new insights into the etiology of pulmonary arterial hypertension is also included. It highlights the complexity involved in managing such patients and the requirement of a multidisiplinary team approach.",
author = "Avdalovic, {Mark V} and Sandrock, {Christian E} and Andrea Hoso and Allen, {Roblee P} and Albertson, {Timothy E}",
year = "2004",
doi = "10.2165/00151829-200403010-00004",
language = "English (US)",
volume = "3",
pages = "29--34",
journal = "Treatments in Respiratory Medicine",
issn = "1176-3450",
publisher = "Adis International Ltd",
number = "1",

}

TY - JOUR

T1 - Epoprostenol in pregnant patients with secondary pulmonary hypertension

T2 - Two case reports and a review of the literature

AU - Avdalovic, Mark V

AU - Sandrock, Christian E

AU - Hoso, Andrea

AU - Allen, Roblee P

AU - Albertson, Timothy E

PY - 2004

Y1 - 2004

N2 - Women who present with pulmonary hypertension during gestation have traditionally been persuaded to terminate their pregnancy. Historically, the mortality associated with this group is very high. Certain patients with a secondary cause of pulmonary hypertension are believed to share similar pathophysiology with primary pulmonary hypertension patients. Recently, new treatments have become available that have slowed disease progression. We present the successful treatment of two patients who presented during late gestation with moderate pulmonary hypertension. Both patients were managed with intravenous vasodilators and anticoagulants without complication. Each patient successfully delivered a healthy child via spontaneous vaginal delivery. The review of the historical management of similar patients including new insights into the etiology of pulmonary arterial hypertension is also included. It highlights the complexity involved in managing such patients and the requirement of a multidisiplinary team approach.

AB - Women who present with pulmonary hypertension during gestation have traditionally been persuaded to terminate their pregnancy. Historically, the mortality associated with this group is very high. Certain patients with a secondary cause of pulmonary hypertension are believed to share similar pathophysiology with primary pulmonary hypertension patients. Recently, new treatments have become available that have slowed disease progression. We present the successful treatment of two patients who presented during late gestation with moderate pulmonary hypertension. Both patients were managed with intravenous vasodilators and anticoagulants without complication. Each patient successfully delivered a healthy child via spontaneous vaginal delivery. The review of the historical management of similar patients including new insights into the etiology of pulmonary arterial hypertension is also included. It highlights the complexity involved in managing such patients and the requirement of a multidisiplinary team approach.

UR - http://www.scopus.com/inward/record.url?scp=1842608806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842608806&partnerID=8YFLogxK

U2 - 10.2165/00151829-200403010-00004

DO - 10.2165/00151829-200403010-00004

M3 - Article

C2 - 15174891

AN - SCOPUS:1842608806

VL - 3

SP - 29

EP - 34

JO - Treatments in Respiratory Medicine

JF - Treatments in Respiratory Medicine

SN - 1176-3450

IS - 1

ER -